HST Global Inc. Net Debt

Net Debt of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt growth rates and interactive chart. Net debt is the sum of all interest-bearing debt (short-term and long-term) minus cash and short-term investments. A positive number indicates the company's total debt exceeds its cash and short-term investments balances, while a negative number means the company has more cash than its total debt. This figure is also used in Enterprise value calculation.


Highlights and Quick Summary

  • Net Debt for the quarter ending June 29, 2020 was $-1.5 Thousand (a -25.0% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt increased by 400.0%
  • Annual Net Debt for 2019 was $-2 Thousand (a 566.67% increase from previous year)
  • Annual Net Debt for 2017 was $-300 (a -40.0% decrease from previous year)
  • Annual Net Debt for 2016 was $-500 (a 150.0% increase from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt of HST Global Inc.

Most recent Net Debtof HSTC including historical data for past 10 years.

Interactive Chart of Net Debt of HST Global Inc.

HST Global Inc. Net Debt for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.0
2019 $-0.0 $-0.02 $-0.0
2017 $-0.0 $-0.0 $-0.0 $-0.0 $-0.0
2016 $-0.0 $-0.0 $-0.0 $0.0 $-0.0
2015 $0.0 $0.0 $0.0 $0.0 $0.0
2014 $0.0 $0.0 $0.0 $-0.0 $0.0
2013 $0.0 $-0.0 $-0.0 $-0.0 $0.0
2012 $-0.0 $-0.0 $-0.0 $-0.0 $-0.0
2011 $-0.0 $-0.0 $-0.0 $-0.0
2010 $-0.0 $0.01 $0.01 $-0.01 $-0.0
2009 $-0.01 $-0.01

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.